Anil Matai

Industry advocacy leader focused on IP, quality, access and innovation — as Director General of OPPI he has emphasized the need for stronger intellectual property protection, higher quality standards in manufacturing and expanded patient access while engaging government and stakeholders to foster an innovation-driven pharmaceutical ecosystem in India. pharmaboardroom+2

Operational executive with deep commercial leadership in pharma — led major India businesses including Zydus Healthcare (Managing Director) and the India formulations business at Zydus Cadila, and previously held senior roles at multinational companies, demonstrating capabilities in scaling organisations and running large P&L operations. zyduslife+2

Advisor and board-level contributor across life sciences and private equity — has worked as Senior Advisor at IQVIA, served as an Operating Partner at Jashvik Capital, and taken independent non-executive board roles, bringing private equity, advisory and corporate governance experience to mid-market healthcare and listed companies. expresspharma+3

Globally-oriented senior executive with formal executive education — has completed senior executive programs at Harvard Business School and IMD, underlining a strategic, international outlook on leadership and governance. ihwcouncil+1